Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment
This project will take place in two phases. In the first phase, the investigators will
utilize pilot testing with 10 participants (two groups of 5 individuals) to integrate two
existing behavioral activation manuals to develop the Behavioral Activation for Drug Abusing
Smokers (BA-DAS). In Phase II, the investigators will randomize 80 patients to either: 1)
standard smoking cessation treatment (ST) and nicotine replacement therapy (NRT) or 2)
BA-DAS (which includes ST and NRT). Based on the outcome of this preliminary trial, the
BA-DAS protocol will be further refined and readied for larger-scale clinical trials to
develop a comprehensive approach to treating smoking among low income, largely minority,
depressed smokers in residential drug use treatment, which may be instrumental in reducing
smoking among this especially at risk group.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Smoking abstinence based on expired carbon monoxide tests, saliva cotinine tests, and self-report
26 weeks post quit date
No
Laura MacPherson, PhD
Principal Investigator
University of Maryland College Park, Center for Addictions, Personality, and Emotions Research (CAPER)
United States: Institutional Review Board
RSGT1101101CPPD
NCT01372254
January 2011
December 2014
Name | Location |
---|---|
Salvation Army Harbor Light Center | Washington, District of Columbia 20002 |